ISACHD Lifetime Achievement Award

ISACHD LIFETIME ACHIEVEMENT AWARD Guidelines

The ISACHD Lifetime Achievement Award recognizes sustained excellence in leadership and innovation through long-term dedication and contributions to, and achievements in, the care of adults with congenital heart disease.

Attributes and Criteria

Competition for this annual Award is open to active or retired caregivers with over 25 years of dedication to the field of adult congenital heart disease.  Nominees should exemplify one or more of the following criteria:

·      demonstrated exceptional leadership and vision in advancing the care of adults with congenital heart disease

·      demonstrated extraordinary commitment to teaching and training in the field of adult congenital heart disease

·      personification of excellence and service as a role model in the care of adults with congenital heart disease

·      demonstrated excellence in research and scholarship leading to considerable advances in the health of adults with congenital heart disease 

·      career-long contributions resulting in a significant and lasting impact to the field of adult congenital heart disease

The Nomination Process

Each nomination package should contain:

1.     A nomination letter from an ISACHD member that includes the name and contact information of the nominee and summarizes the candidate’s accomplishments relevant to the Award; 

2.     Two letters of support that identify specific examples of contributions made by the candidate, which qualify him or her for the Award.  These letters of support need not be from ISACHD members;

3.     The candidate’s curriculum vitae       

The nomination packet, including letters and curriculum vitae, should be addressed to the ISACHD Executive Committee and must be received by Monday, September 5, 2016.  The nomination packet should be sent electronically to Dr. Erwin Oechslin, ISACHD President, at erwin.oechslin@uhn.ca.

The Award will be presented at ISACHD’s biannual meeting in November 2016 which will be held in Orlando during the American Heart Association Scientific Sessions.